Related Experiment Video
Updated: May 20, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
The future of HIV treatment
Martin S Hirsch1, Daniel R Kuritzkes
1Department of Medicine, Massachusetts General Hospital, Boston MA, USA. hirsch.martin@mgh.harvard.edu
Journal of Acquired Immune Deficiency Syndromes (1999)
|July 10, 2012
Summary
Antiretroviral therapy has advanced HIV management, but challenges like eradicating HIV reservoirs and ensuring global drug access persist. Future efforts must focus on novel treatments and equitable distribution for all HIV-infected individuals.
Area of Science:
- Infectious Diseases
- Virology
- Public Health
Background:
- Antiretroviral therapy (ART) has significantly improved outcomes for individuals with human immunodeficiency virus (HIV) infection.
- Despite advances, lifelong ART is currently required due to persistent viral reservoirs.
- Global disparities in access to ART highlight ongoing challenges in HIV management.
Purpose of the Study:
- To summarize the current state of antiretroviral therapy for HIV.
- To identify key challenges in HIV management, including viral eradication and drug accessibility.
- To emphasize the need for improved drug development and equitable access to treatment.
Main Methods:
- Review of current antiretroviral therapy strategies.
- Analysis of challenges in HIV reservoir eradication.
- Assessment of drug development, clinical trial, and regulatory pathways.
- Examination of global antiretroviral drug access and distribution.
Main Results:
- ART has transformed HIV care but has not led to a cure.
- Persistent HIV reservoirs present a major obstacle to treatment-free remission.
- Inefficiencies in drug development and regulatory processes can delay novel therapeutic introductions.
- Significant disparities in ART availability exist in underserved regions worldwide.
Conclusions:
- Eradicating HIV reservoirs is crucial for achieving a functional cure.
- Streamlining drug development and regulatory pathways is essential for rapid evaluation of new HIV interventions.
- Global partnerships are vital to overcome antiretroviral drug scarcity and ensure equitable access to life-saving HIV treatment.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:26Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:26Human Virome
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...